We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$21.2B
AUM Growth
+$1.07B
(+5.3%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
9.44%
Holding
1,639
New
311
Increased
467
Reduced
550
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$211M |
| 2 |
AbbVie
ABBV
|
+$176M |
| 3 |
Apple
AAPL
|
+$170M |
| 4 |
Nike
NKE
|
+$161M |
| 5 |
Coca-Cola
KO
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$221M |
| 2 |
Medtronic
MDT
|
+$163M |
| 3 |
UnitedHealth
UNH
|
+$148M |
| 4 |
Johnson & Johnson
JNJ
|
+$133M |
| 5 |
Pfizer
PFE
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Consumer Discretionary | 14.98% |
| 3 | Healthcare | 13.91% |
| 4 | Financials | 10.93% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Cincinnati Financial
CINF
$26.5B
| $12.7M | 0.06% |
+130,061
| New | +$13.4M |
|
402
Pacific Biosciences
PACB
$336M
| $12.6M | 0.06% |
950,464
-764,942
| -45% | -$9.3M |
|
|
AZUL
403
DELISTED
Azul
AZUL
| $12.5M | 0.06% |
916,665
+66,419
| +8% | +$604K |
|
404
Logitech
LOGI
$14.5B
| $12.5M | 0.06% |
210,778
-52,948
| -20% | -$3.2M |
|
405
Armstrong World Industries
AWI
$7.73B
| $12.5M | 0.06% |
169,898
+73,476
| +76% | +$5M |
|
406
J.M. Smucker
SJM
$12.7B
| $12.4M | 0.06% |
84,210
+44,099
| +110% | +$6.73M |
|
407
NVR
NVR
$16.8B
| $12.4M | 0.06% |
+1,948
| New | +$11.3M |
|
408
Acadia Pharmaceuticals
ACAD
$5.12B
| $12.3M | 0.06% |
514,574
+298,642
| +138% | +$6.64M |
|
409
MSCI
MSCI
$40.7B
| $12.3M | 0.06% |
26,244
+13,032
| +99% | +$6.36M |
|
410
Impinj
PI
$5.49B
| $12.3M | 0.06% |
137,142
-36,355
| -21% | -$3.87M |
|
|
TXNM
411
TXNM Energy Inc
TXNM
$5.91B
| $12.3M | 0.06% |
272,485
-3,236
| -1% | -$152K |
|
412
JD.com
JD
$42.2B
| $12.2M | 0.06% |
+357,163
| New | +$13M |
|
413
JB Hunt Transport Services
JBHT
$25.7B
| $12.1M | 0.06% |
+67,108
| New | +$11.7M |
|
414
CubeSmart
CUBE
$9.3B
| $12.1M | 0.06% |
271,797
+193,385
| +247% | +$8.78M |
|
415
L3Harris
LHX
$52.8B
| $12.1M | 0.06% |
61,653
-18,678
| -23% | -$3.57M |
|
416
Live Nation Entertainment
LYV
$43.1B
| $12M | 0.06% |
131,485
-232,917
| -64% | -$18.2M |
|
|
PPLI
417
People Inc
PPLI
$3.03B
| $11.9M | 0.06% |
231,467
-235,440
| -50% | -$10.8M |
|
|
PINC
418
DELISTED
Premier
PINC
| $11.9M | 0.06% |
430,942
+187,658
| +77% | +$5.36M |
|
|
P
419
Everpure Inc
P
$36.7B
| $11.9M | 0.06% |
+322,902
| New | +$9.15M |
|
|
BNY
420
Bank of New York Mellon
BNY
$111B
| $11.9M | 0.06% |
266,267
-12,065
| -4% | -$518K |
|
421
Helmerich & Payne
HP
$4.28B
| $11.8M | 0.06% |
333,084
+311,139
| +1,418% | +$10.6M |
|
422
Symbotic
SYM
$5.33B
| $11.8M | 0.06% |
+275,456
| New | +$9.05M |
|
423
Royalty Pharma
RPRX
$26.2B
| $11.8M | 0.06% |
382,729
-55,272
| -13% | -$1.87M |
|
424
Tenet Healthcare
THC
$21.3B
| $11.7M | 0.06% |
144,238
+82,979
| +135% | +$5.91M |
|
|
ABCM
425
DELISTED
Abcam PLC
ABCM
| $11.7M | 0.06% |
+476,530
| New | +$8.22M |
|
Similar funds
CS
VAI
Voloridge Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Voloridge Investment Management held 1,639 positions worth $21.2B, up 5.3% from $20.1B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Voloridge Investment Management's Q2 2023 filing shows 311 new, 467 increased, 550 reduced and 311 closed positions. Its largest new stake was Berkshire Hathaway Class B: 646,010 shares worth $220M. The largest sale was Accenture, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Voloridge Investment Management's largest Q2 2023 buy was Berkshire Hathaway Class B: 646,010 shares worth $220M.
- Voloridge Investment Management added most to Coca-Cola in Q2 2023, an estimated $141M increase.
- Voloridge Investment Management's biggest Q2 2023 reduction was Medtronic, cutting an estimated $163M.
- Voloridge Investment Management fully exited Accenture in Q2 2023, selling an estimated $221M.
- Voloridge Investment Management's ten largest holdings make up 9.4% of its $21.2B portfolio in Q2 2023.
- Voloridge Investment Management opened 311 new positions and closed 311 in Q2 2023.
- Voloridge Investment Management's portfolio value rose 5.3% quarter-over-quarter to $21.2B.
Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.